Diatreme Resources (ASX:DRX) is an emerging Australian producer of mineral and silica sands based in Brisbane. Our key projects comprise the Northern Silica Project and Galalar Silica Sand Project in Far North Queensland, located next to the world's biggest silica sand mine at Cape Flattery.
Copyright 2024 – Finance News Network
07 Dec 2020 - The Agency Group Australia Limited (ASX:AU1) Managing Director Paul Niardone talks FY20 results, strategy and outlook following the company's new funding package.
28 Oct 2024 - Australia's Chief Scientist, Dr Cathy Foley, AO PSM, presents at the Semiconductor Australia 2024 conference. She highlights Australia’s strengths in tech development and outlines a vision for a sustainable economy led by innovation.
07 Sep 2023 - Empire Energy Group (ASX:EEG) CEO Alex Underwood discusses large scale future well drilling projects, and anticipates commercial production by 2025.
01 Mar 2021 - IVE Group Limited (ASX:IGL) Executive Chairman Geoff Selig talks about the company's strong 1H21 results on the back of a rebound in activity as the adverse impact of COVID disruptions diminishes.
31 Mar 2020 - BluGlass Limited (ASX:BLG) Managing Director and CEO,Giles Bourne, talks about the company's 1:1 non-renounceable rights issue, the need to fund its technology through to commercialisation, independent validation of its RPCVD technology and its response to COVID-19.
10 Nov 2023 - A recent interview between Wexted Advisors and Finance News Network, sparked an impromptu conversation between former Wallabies Captain Simon Poidevin and Head of Sequoia Direct Paul Sanger, discussing the controversial current climate of the Rugby World Cup.
06 Jul 2023 - There has been a global underinvestment in heavy mineral sands projects over the past decade. Newly debuting Chilwa Minerals (ASX:CHW) aims to address this shortage.
16 Dec 2019 - Sienna Cancer Diagnostics Limited (ASX:SDX) Managing Director and CEO Carl Stubbings talks about the company's capital raising and co-development of tests using its SIEN-NET liquid biopsies platform technology.
27 Jun 2023 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses promising results in the company's lead therapy for glioblastoma, and the timeline for the recently launched Phase 1b trial.